In this article published in The Pink Sheet, Tim Wilsdon and Ryan Lawlor explore the relationship between various procurement models and vaccine coverage rates in Europe. They discuss how certain procurement methods help contribute to a sustainable “vaccine ecosystem.”
To read the article, click here.
Note: subscription required to access
Beyond the single asset: The rise of combination and synergistic innovation in neurology drug development
Introduction Historically, drug development within the neurology space has been characterized by the search for individual therapies that can arrest complex...